111 related articles for article (PubMed ID: 19275963)
1. Selective, potent PPARgamma agonists with cyclopentenone core structure.
Otero MP; Pérez Santín E; Rodríguez-Barrios F; Vaz B; de Lera AR
Bioorg Med Chem Lett; 2009 Apr; 19(7):1883-6. PubMed ID: 19275963
[TBL] [Abstract][Full Text] [Related]
2. 1,3-Diphenyl-1H-pyrazole derivatives as a new series of potent PPARγ partial agonists.
Choi J; Park Y; Lee HS; Yang Y; Yoon S
Bioorg Med Chem; 2010 Dec; 18(23):8315-23. PubMed ID: 21030263
[TBL] [Abstract][Full Text] [Related]
3. Identification of (beta-carboxyethyl)-rhodanine derivatives exhibiting peroxisome proliferator-activated receptor gamma activity.
Choi J; Ko Y; Lee HS; Park YS; Yang Y; Yoon S
Eur J Med Chem; 2010 Jan; 45(1):193-202. PubMed ID: 19879669
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of azaindole-alpha-alkyloxyphenylpropionic acid analogues as PPARalpha/gamma agonists.
Cai Z; Feng J; Guo Y; Li P; Shen Z; Chu F; Guo Z
Bioorg Med Chem; 2006 Feb; 14(3):866-74. PubMed ID: 16249089
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, in vitro and in silico evaluation of l-tyrosine containing PPARalpha/gamma dual agonists.
Kumar R; Ramachandran U; Khanna S; Bharatam PV; Raichur S; Chakrabarti R
Bioorg Med Chem; 2007 Feb; 15(3):1547-55. PubMed ID: 17166722
[TBL] [Abstract][Full Text] [Related]
6. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
[TBL] [Abstract][Full Text] [Related]
7. Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists.
Lin CH; Peng YH; Coumar MS; Chittimalla SK; Liao CC; Lyn PC; Huang CC; Lien TW; Lin WH; Hsu JT; Cheng JH; Chen X; Wu JS; Chao YS; Lee HJ; Juo CG; Wu SY; Hsieh HP
J Med Chem; 2009 Apr; 52(8):2618-22. PubMed ID: 19301897
[TBL] [Abstract][Full Text] [Related]
8. 4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARalpha/gamma agonists. Part. II: Synthesis and pharmacological evaluation of oxime and acidic head group structural variations.
Parmenon C; Guillard J; Caignard DH; Hennuyer N; Staels B; Audinot-Bouchez V; Boutin JA; Dacquet C; Ktorza A; Viaud-Massuard MC
Bioorg Med Chem Lett; 2009 May; 19(10):2683-7. PubMed ID: 19376700
[TBL] [Abstract][Full Text] [Related]
9. 7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
Matin A; Gavande N; Kim MS; Yang NX; Salam NK; Hanrahan JR; Roubin RH; Hibbs DE
J Med Chem; 2009 Nov; 52(21):6835-50. PubMed ID: 19807106
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and evaluation of 2-alkoxydihydrocinnamates as PPAR agonists.
Lu Y; Guo Z; Guo Y; Feng J; Chu F
Bioorg Med Chem Lett; 2006 Feb; 16(4):915-9. PubMed ID: 16300944
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design of indole propionic acids as novel PPARalpha/gamma co-agonists.
Kuhn B; Hilpert H; Benz J; Binggeli A; Grether U; Humm R; Märki HP; Meyer M; Mohr P
Bioorg Med Chem Lett; 2006 Aug; 16(15):4016-20. PubMed ID: 16737814
[TBL] [Abstract][Full Text] [Related]
12. (Arylthio)cyclopentenones derivatives prevent glutamate-induced HT22 cell death through a PPAR gamma-dependent pathway.
Shibata S; Furuta K; Maeda M; Suzuki M; Oh-Hashi K; Kiuchi K; Hirata Y
Brain Res; 2009 Nov; 1296():196-202. PubMed ID: 19686707
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a peroxisome proliferator activated receptor gamma (PPARgamma) modulator with balanced PPARalpha activity for the treatment of type 2 diabetes and dyslipidemia.
Liu W; Liu K; Wood HB; McCann ME; Doebber TW; Chang CH; Akiyama TE; Einstein M; Berger JP; Meinke PT
J Med Chem; 2009 Jul; 52(14):4443-53. PubMed ID: 19530681
[TBL] [Abstract][Full Text] [Related]
14. Novel 1,3-dicarbonyl compounds having 2(3H)-benzazolonic heterocycles as PPARgamma agonists.
Blanc-Delmas E; Lebegue N; Wallez V; Leclerc V; Yous S; Carato P; Farce A; Bennejean C; Renard P; Caignard DH; Audinot-Bouchez V; Chomarat P; Boutin J; Hennuyer N; Louche K; Carmona MC; Staels B; Pénicaud L; Casteilla L; Lonchampt M; Dacquet C; Chavatte P; Berthelot P; Lesieur D
Bioorg Med Chem; 2006 Nov; 14(22):7377-91. PubMed ID: 16887353
[TBL] [Abstract][Full Text] [Related]
15. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.
Kim MK; Chae YN; Kim HS; Choi SH; Son MH; Kim SH; Kim JK; Moon HS; Park SK; Shin YA; Kim JG; Lee CH; Lim JI; Shin CY
Arch Pharm Res; 2009 May; 32(5):721-7. PubMed ID: 19471887
[TBL] [Abstract][Full Text] [Related]
16. Identification of a PPARdelta agonist with partial agonistic activity on PPARgamma.
Connors RV; Wang Z; Harrison M; Zhang A; Wanska M; Hiscock S; Fox B; Dore M; Labelle M; Sudom A; Johnstone S; Liu J; Walker NP; Chai A; Siegler K; Li Y; Coward P
Bioorg Med Chem Lett; 2009 Jul; 19(13):3550-4. PubMed ID: 19464171
[TBL] [Abstract][Full Text] [Related]
17. 4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARalpha/gamma agonists. Part I: synthesis and pharmacological evaluation.
Parmenon C; Guillard J; Caignard DH; Hennuyer N; Staels B; Audinot-Bouchez V; Boutin JA; Dacquet C; Ktorza A; Viaud-Massuard MC
Bioorg Med Chem Lett; 2008 Mar; 18(5):1617-22. PubMed ID: 18255290
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationship of novel indene N-oxide derivatives as potent peroxisome proliferator activated receptor gamma (PPARgamma) agonists.
Ahn JH; Shin MS; Jung SH; Kim JA; Kim HM; Kim SH; Kang SK; Kim KR; Rhee SD; Park SD; Lee JM; Lee JH; Cheon HG; Kim SS
Bioorg Med Chem Lett; 2007 Sep; 17(18):5239-44. PubMed ID: 17624777
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and structure-activity relationships of azole acids as novel, potent dual PPAR alpha/gamma agonists.
Zhang H; Ryono DE; Devasthale P; Wang W; O'Malley K; Farrelly D; Gu L; Harrity T; Cap M; Chu C; Locke K; Zhang L; Lippy J; Kunselman L; Morgan N; Flynn N; Moore L; Hosagrahara V; Zhang L; Kadiyala P; Xu C; Doweyko AM; Bell A; Chang C; Muckelbauer J; Zahler R; Hariharan N; Cheng PT
Bioorg Med Chem Lett; 2009 Mar; 19(5):1451-6. PubMed ID: 19201606
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel PPARalpha ligands by the structural modification of a PPARgamma ligand.
Usui S; Fujieda H; Suzuki T; Yoshida N; Nakagawa H; Miyata N
Bioorg Med Chem Lett; 2006 Jun; 16(12):3249-54. PubMed ID: 16621530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
